Advisory Committee

Quartulain (Ainy) Saeed, MHA, MBA, is a Service Line Director at M Fairview Health Services. As Service Line Director, Ainy leads the development and implementation of business, growth and marketing strategies, as well as develops and implements policies, procedures, and budgets.  She also facilitates the transition of new clinical therapies from research pipeline into clinical practice, while presiding over and ensuring regulatory compliance. She is also responsible for the development of the Blood & Marrow Transplant and Cellular Therapy program.

Ainy Saeed is a graduate of The University of Minnesota, where she earned a Master of Health Administration and Master of Business Administration. She received a Bachelor of Science degree in Biology from Purdue University.

Jessica Unzaga, PharmD, BCPS, BCOP, is a clinical pharmacy coordinator at the Miami Cancer Institute at Baptist Health South Florida. Dr. Unzaga carries dual board certification in pharmacotherapy (BCPS) and oncology pharmacy (BCOP). She has served many roles in the inpatient and outpatient oncology service lines including inpatient malignant hematology, outpatient oral chemotherapy clinic for solid tumor and hematologic malignancies, and outpatient bone marrow transplantation.

Dr. Unzaga is an active preceptor and mentor for pharmacy students and residents on clinical rotations in hematology and bone marrow transplantation. She is a courtesy clinical assistant professor for the University of Florida College of Pharmacy and invited lecturer for pharmacotherapy of lymphomas and multiple myeloma for the Larkin University College of Pharmacy. Additionally, she is an active member of the Hematology/Oncology Pharmacy Association (HOPA), American Society of Hematology (ASH), American Society of Transplantation and Cellular Therapy (ASTCT), Florida Society of Clinical Oncology (FLASCO), and Florida Society of Health System Pharmacists Southeast Society (SE-FSHP).

She is a graduate of the University of Florida College of Pharmacy and completed her post-graduate year (PGY) 1 and 2 residencies at the Veterans Affairs Tennessee Valley Healthcare System (VA TVHS) in Nashville, Tennessee, at Methodist University Hospital and the West Cancer Center, respectively.

Dan Vogl, MD MSCE, is Medical Director of the Abramson Cancer Center Clinical Research Unit at the University of Pennsylvania Perelman School of Medicine, overseeing the work of over 100 research nurses, research coordinators, regulatory coordinators, and biospecimen coordinators, who together manage over 300 active cancer clinical trials. His clinical research focuses on early phase trials of novel agents for the treatment of relapsed and refractory multiple myeloma. Dr. Vogl is a medical oncologist and hematologist who specializes in caring for patients with plasma cell malignancies, including multiple myeloma and AL amyloidosis.

Dr. Vogl is a graduate of Weill Medical College of Cornell University and has a Masters of Science in Clinical Epidemiology from the University of Pennsylvania. He completed training in Internal Medicine at Columbia-Presbyterian Hospital in New York and in Hematology and Oncology at the Hospital of the University of Pennsylvania.